Association of MPOD Values With Blue Light.
NCT04779398 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 96
Last updated 2022-05-19
Summary
This study aims to investigate in healthy adults 18-65 years of age the association of electronic device blue light exposure and macular pigment optical density (MPOD) considering usual dietary intake of lutein and zeaxanthin (L/Z) as confirmed by serum lutein and zeaxanthin concentrations.
It is hypothesised in healthy adults 18-65 years of age:
1. Higher usual daily electronic device blue light exposure will be negatively correlated with MPOD value.
2. Usual dietary intake of L/Z will be positively correlated with MPOD value.
3. L/Z concentration will be positively correlated with MPOD value.
4. Usual dietary intake of L/Z will be positively correlated with plasma L/Z concentrations.
5. Higher usual intake of L/Z will mitigate the effect of higher electronic device exposure on MPOD value.
Conditions
- Age Related Macular Degeneration
Sponsors & Collaborators
-
The University of Queensland
lead OTHER
Principal Investigators
-
Veronique Chachay, PhD · The University of Queensland
Eligibility
- Min Age
- 18 Years
- Max Age
- 65 Years
- Sex
- ALL
- Healthy Volunteers
- Yes
Timeline & Regulatory
- Start
- 2020-09-25
- Primary Completion
- 2022-03-31
- Completion
- 2022-03-31
Countries
- Australia
Study Locations
More Related Trials
-
Macular Pigment Measurements in Eye & Other Tissues
NCT03022773 ·Status: ENROLLING_BY_INVITATION ·Phase: NA
-
Effects of Xanthophylls on Optical Density
NCT01316198 ·Status: COMPLETED ·Phase: NA
-
Carotenoid Supplementation and Retinal Health in Healthy Adults
NCT07314411 ·Status: RECRUITING ·Phase: NA
-
Role of Xanthophylls in Visual Function
NCT05794074 ·Status: NOT_YET_RECRUITING ·Phase: NA
-
MPOD in Macular Teleangiectasia Following Supplementation of Lutein and Zeaxanthin
NCT00568828 ·Status: UNKNOWN
-
Effects of Antioxidants on Human Macular Pigments
NCT00718653 ·Status: COMPLETED ·Phase: NA
-
Lutein Bioavailability From Fresh and Dried Beverages
NCT01400763 ·Status: COMPLETED ·Phase: NA
-
Effects of Lutein and Zeaxanthin Supplementation on Age-related Macular Degeneration
NCT01048476 ·Status: UNKNOWN ·Phase: PHASE1/PHASE2
-
Investigation of the Genetic and Environmental Determinants of MP Including Response to Supplementation
NCT01778231 ·Status: COMPLETED ·Phase: NA
-
Regional Kale as Source of Lutein and Zeaxanthin to Improve Vision of AMD-patients
NCT02136303 ·Status: UNKNOWN ·Phase: NA
-
The Influence of Lutein Supplements on Age-related Macular Degeneration
NCT01042860 ·Status: COMPLETED ·Phase: NA
-
Study of the Macular Pigment by the Consumption of Corn With Strong Content in Zeaxanthine
NCT02113254 ·Status: TERMINATED ·Phase: NA
-
The Zeaxanthin and Visual Function Study
NCT00564902 ·Status: COMPLETED ·Phase: NA
-
Consumption of Eggs Rich in Lutein and Omega-3 Fatty Acids on the Macular Pigment
NCT01480700 ·Status: COMPLETED ·Phase: NA
-
Effect of Lutein, Zeaxanthin, and Meso-Zeaxanthin Supplementation on Skin Carotenoid Concentration: A Six-Month, Placebo-Controlled Crossover Study
NCT06965426 ·Status: RECRUITING ·Phase: NA
-
Lutein/Zeaxanthin and Omega-3 Supplementation in Persons Over Age 60
NCT00121589 ·Status: COMPLETED ·Phase: PHASE1
-
Macular Pigment Density Evolution in Unilateral Wet AMD Versus Non AMD Patients With or Without Lutein and Zeaxanthine Supplementation
NCT01404845 ·Status: COMPLETED ·Phase: NA
-
Effects of Lutein and Zeaxanthin Supplementation on Early Age-related Macular Degeneration
NCT01528605 ·Status: COMPLETED ·Phase: NA
-
Lutein for Age-Related Macular Degeneration
NCT00006202 ·Status: COMPLETED ·Phase: PHASE2
-
Association of Lutein, Zeaxanthin and Brilliant Blue in Chromovitrectomy
NCT01627977 ·Status: COMPLETED ·Phase: PHASE3
-
Lutein Influence on Macula of Persons Issued From Amd Parents
NCT01269697 ·Status: COMPLETED ·Phase: PHASE3
-
Long Term Effects of Lutein/Zeaxanthin and Omega-3- Supplementation on Optical Density of AMD Patients (LUTEGA)
NCT00763659 ·Status: COMPLETED ·Phase: NA
-
Addition of 20mg/Day Zeaxanthin to Triple Therapy Treatment Options for Age Related Macular Degeneration (ARMD)
NCT01527435 ·Status: COMPLETED
-
Lutein & Zeaxanthin in Pregnancy - Carotenoid Supplementation During Pregnancy: Ocular and Systemic Effects
NCT03750968 ·Status: COMPLETED ·Phase: PHASE2
-
CArotenoid in hypoChOlesterolemia
NCT05208879 ·Status: COMPLETED